Login to Your Account

financings NEWS

SHANGHAI – Zai Lab Inc., of Shanghai, has received $30 million in financing from a group of international venture capital investors, led by the well-respected Qiming Venture Partners LLC, headquartered in Hong Kong. The series A funding will support Zai's pursuit of its "virtual" business model.

Cellular immunotherapy firm Bellicum Pharmaceuticals Inc. landed $55 million in an oversubscribed series C less than eight months after closing its $34.4 million B round, raising the company's total haul to $107 million since launching in 2004.
With its inhaled levodopa product for Parkinson's disease (PD) gearing up for a phase III trial and $55 million just gained in a series C financing, Civitas Therapeutics Inc. filed to raise up to $86.2 million in an initial public offering (IPO).
More financings Headlines

Cast Your Vote

Has biotech’s bubble burst?: